Product Information
SOLOSEC 2 GM GRANULE PACKET is a brand product labeled by Evofem Inc., priced at $281.9575 per EA under NDC 69751040001. Its NADAC has been published 64 times since Jul 16, 2025.
FDA first approved this application on Sep 15, 2017.
Strength
2 g/4.8g
Manufacturer
Evofem Inc.NDC
69751040001
Classification
Brand
Dosage Form
GRANULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SECNIDAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA209363FDA Approved
9/15/2017
On Market Since
5/31/2018
Pharmacological Classes
Price Statistics
The NADAC for SOLOSEC 2 GM GRANULE PACKET has been published 64 times since Jul 16, 2025, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $281.9575 per EA |
|---|---|
| All-time high | $283.1544 (May 13, 2026) |
| All-time low | $271.0058 (Nov 19, 2025) |
| 52-week high | $283.1544 |
| 52-week low | $271.0058 |
| Median price | $281.5473 |
| Average price | $278.4909 |
| Largest weekly change | +4.0% (Dec 31, 2025) |
| Weeks tracked | 64 |
| Tracking since | Jul 16, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the secnidazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Evofem Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
secnidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOLOSEC 2 GM GRANULE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for SOLOSEC 2 GM GRANULE PACKET, manufactured by Evofem Inc., is $281.9575 per EA (NDC 69751040001), effective Sep 30, 2026.
How has the price of SOLOSEC 2 GM GRANULE PACKET changed over time?
Over the history we have for it, the NADAC for SOLOSEC 2 GM GRANULE PACKET has risen 3.6%. It has been tracked across 64 weekly CMS publications since Jul 16, 2025.
What are the highest and lowest recorded NADAC prices for SOLOSEC 2 GM GRANULE PACKET?
Since Jul 16, 2025, the NADAC for SOLOSEC 2 GM GRANULE PACKET has ranged from a low of $271.0058 (Nov 19, 2025) to a high of $283.1544 (May 13, 2026), with a median of $281.5473 per EA.
Are there cheaper alternatives to SOLOSEC 2 GM GRANULE PACKET?
No other NADAC-published product currently shares the active ingredient and strength of SOLOSEC 2 GM GRANULE PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SOLOSEC 2 GM GRANULE PACKET?
SOLOSEC 2 GM GRANULE PACKET (NDC 69751040001) is labeled by Evofem Inc., and CMS classifies it as a brand product.